Most are comfortable with treatment during pandemic
A Medical Technology Group survey shows that patients are embracing technology during the COVID-19 pandemic, but still value real-life consultations.
Transferrin identified as potential contributor to COVID-19 severity
The University of Kent's School of Biosciences and the Institute of Medical Virology at Goethe-University, Frankfurt am Main, have identified that a glycoprotein known as transferrin may critically contribute to severe forms of COVID-19.
Take, Test and Treat: a free series of webinars
BD has teamed up with CloserStill Media, organisers of Health Plus Care, to present ‘Take, Test and Treat – The critical future in diagnostics and blood culture’ webinar series, taking place online on 8, 9 and 10 September.
Blood clots and lung injuries found in patients who have died of COVID
A new post-mortem study of patients who have died from COVID-19 found severe damage to the lungs and signs of blood clotting in major organs.
Ecolab to deliver five million litres of hand sanitiser to the NHS
Ecolab has been asked to supply NHS Supply Chain with five million litres of hand sanitiser by the end of the year, to meet increased demand in the wake of COVID-19.
Chemo doorstep drops help to keep cancer patients safe
Thousands of patients with cancer have had chemotherapy delivered to their doors so that they can more safely receive treatment during the coronavirus pandemic.
Expansion of COVID-19 infection survey announced for UK
The ONS COVID-19 Infection Survey tracking the virus in the general population will be expanded from regularly testing 28,000 people per fortnight in England to 150,000 by October, the Health Secretary has announced.
COVID-19 drives new NHS contracts for clinical decision support tool
Wolters Kluwer Health has won seven new NHS contracts for its clinical decision support tool UpToDate, as hospitals have turned to evidence-based support during the COVID-19 crisis.
Study finds 6% of the population have antibodies to the Coronavirus
More than 100,000 people across England have tested themselves for SARS-CoV-2 antibodies at home as part of a major research programme.
New research to investigate COVID-19 and ethnicity
The Medical Research Council (MRC) and the National Institute for Health Research (NIHR) have announced a multi-million-pound investment in six new projects to improve understanding of the links between COVID-19 and ethnicity.
Surgical instrument manufacturer to package and sterilise PPE for NHS
Single Use Surgical, part of Eakin Healthcare Group, has signed a contract to package and sterilise 1.92 million surgical isolation gowns – a move that will create 45 new jobs and protect frontline NHS staff against COVID-19.
Roll-out of two new rapid coronavirus tests ahead of winter
Millions of rapid coronavirus tests will be rolled out to hospitals, care homes and labs across the UK to increase testing capacity ahead of winter.
Two thirds of doctors worry that COVID has indirectly harmed patients
A survey of members of the Royal College of Physicians (RCP) has found that almost two thirds (60%) of doctors worry that patients in their care have suffered harm or complications following diagnosis or treatment delays during the pandemic.
UK and US healthcare workers report higher rates of COVID-19
Frontline healthcare workers in the UK and US were at least 3.4 times more likely to report a positive COVID-19 test compared with the general community, after accounting for differences in testing frequency between the two groups.
Common cancer treatments ‘do not worsen coronavirus infection’
According to a new study from Memorial Sloan Kettering, published in Nature Medicine, patients in active cancer treatment who develop COVID-19 infection don't fare any worse than other hospitalised patients.
Asthma not a compounding factor for COVID-19 cases
A study by researchers at Bicêtre Hospital, on patients hospitalised for COVID-19, has shown that asthmatics do not present an increased risk of developing a severe form of the disease.
UK COVID-19 rapid antibody tests are approved for professional use
The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium (UK-RTC), has received its CE mark. This means it is approved for professional use in the UK and EU.
NICE publishes guideline on planned hospital treatments
NICE has published a guideline on the arrangements the NHS should put in place for patients needing elective surgery and other planned treatments and procedures (including diagnostics and imaging) during the COVID-19 pandemic.
Government advice on masks ‘confusing’ warns BMA
The BMA has warned that Government measures and public guidance on face covering rules in England are unclear, inconsistent and are causing widespread confusion.
Scanning solution helps tackle COVID pressures at North Tees
North Tees and Hartlepool NHS Foundation Trust has implemented a containerised CT scanning solution that will help meet increased demand for scanning services, during the COVID crisis, while protecting non-infected patients.
Löwenstein Medical UK Ltd. is a UK subsidiary of Löwenstein Group and represents Löwenstein Medical products. Offering a full range of anaesthesia workstations, neonatal ventilators, ICU-ventilators and sleep diagnostics and therapy devices, including high quality masks for the UK market.
Hygiene and sustainability in endoscopy: finding the balance
Thursday 22nd June 2023
EBME Expo 2023
Judds Lane, Coventry, England, GB, CV6 6
28th - 29th June 2023
AfPP Annual Conference 2023
University of York
10- 13 August 2023
MEDICA - Leading International Trade Fair
Schadowstraße 49, 40212 Düsseldorf, Germany
13- 16 November 2023
Excel Centre London
14 - 15 November 2023
IPS IV Forum Annual Conference 2023
24th November 2023
Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.
Download the FREE Clinical Services Journal app from your device's App store